B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts
Research output: Contribution to journal › Journal article › Research › peer-review
Background: Plasma concentrations of B-type natriuretic peptide (BNP-32) and its precursor (proBNP) are increased in chronic heart failure. Accordingly, BNP-32 and proBNP are both being implemented as clinical markers. Aim: To determine the molar relation of BNP-32 and proBNP in different cardiovascular regions. Methods and results: Blood samples were obtained from different cardiovascular regions during right heart catheterization in heart failure patients, and from normal subjects. Plasma BNP-32 and proBNP concentrations were measured using sequence-specific radioimmunoassays. Patients with severe left ventricular dysfunction (n=21) displayed increased peripheral plasma concentrations of both BNP-32 (four-fold, P=0.0008) and proBNP (seven-fold, P=0.0002) compared with normal subjects. Moreover, the peripheral concentrations were highly correlated with the corresponding concentrations in the coronary sinus (BNP-32: r=0.97, P<0.0001; proBNP: r=0.94, P<0.0001). Despite comparable peripheral concentrations of BNP-32 and proBNP, the BNP-32 concentration was higher than the proBNP concentration in the coronary sinus (median 126 pmol/l (21-993) vs. 103 pmol/l (16-691), P=0.035). Conclusions: The BNP-32 and proBNP concentrations are closely related in venous cardiac blood. The findings suggest an overall constitutive secretion of processed proBNP, i.e. an N-terminal precursor fragment and BNP-32, in chronic heart failure.
Original language | English |
---|---|
Journal | European Journal of Heart Failure |
Volume | 7 |
Issue number | 1 |
Pages (from-to) | 69-74 |
Number of pages | 6 |
ISSN | 1388-9842 |
DOIs | |
Publication status | Published - Jan 2005 |
- B-type natriuretic peptide, Cardiac secretion, Heart failure, Natriuretic peptide, proBNP
Research areas
ID: 310766766